Alkermes Shareholders Reject All of Sarissa's Nominees for Its Board
The biopharma company instead chose to re-elect its existing board members.
Stay updated with breaking news from Christopheri Wright. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biopharma company instead chose to re-elect its existing board members.
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced that, at the Company's 2023 Annual General Meeting of Shareholders (the Annual...
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced that independent shareholder advisory firm Institutional Shareholder Services (ISS)...
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company's upcoming 2023 Annual...
Sarissa's Proposed Candidates Would Not Bring New Skills to the Board Recommends Shareholders Vote "FOR" Alkermes' Director Nominees on Company's WHITE Proxy Card DUBLIN, June 13,